Indiana University

Is extended treatment timeframe following strokes sound science?

views 464
Air date: July 8, 2012

Host: David Crabb, MD

Men's & Women's Health Research Safety
Email Email
Share Sound Medicine Share this segment
MP3 download Download MP3

Interview: Gregory del Zoppo, Professor of Medicine, Division of Hematology, University of Washington School of Medicine



Tissue plasminogen activator, otherwise known as tPA, has been critical in dissolving blood clots in stroke patients. Current recommendations dictate that this powerful drug should be administered within three hours, but new studies suggest tPA is still beneficial within a six-hour time frame. Gregory del Zoppo, M.D., professor of medicine in the Division of Hematology at the University of Washington School of Medicine, discusses the implications of this study for stroke patients and the history of tPA.

Find us on:

Sound Medicine facebook fan page Follow Sound Medicine on twitter

Listen to us free at:

Sound Medicine on Stitcher

Promo code: Sound